Alternatives to NVision Imaging

A global medical technology, diagnostics, and digital solutions innovator, providing integrated solutions for precision health.

Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.

Develops AI-driven, real-time intraoperative imaging for early lung cancer diagnostics and treatment.

AI-powered real-time guidance and quality assessment for cardiac ultrasound imaging.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Surgical Theater combines fighter jet flight simulation technology with patient anatomy scans to create 360°-3D virtual reality for surgical planning and navigation.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

MedHub-AI develops an AI-based decision support system for interventional cardiologists to enable precision cardiac care.

Liger Medical develops breakthrough optical diagnostic devices and software for early cancer detection and other medical purposes.

Develops AI-powered software for automated analysis of cardiac and cardiovascular medical images.

AI-powered care coordination platform for faster diagnosis and treatment of critical conditions.

AI-powered platform for cancer diagnostics in digital pathology.

Digital physical therapy and recovery platform using everyday sensors for ongoing health diagnostics.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

Medical technology company optimizing coronary artery disease therapy decisions with FFR-based assessment.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.